Abstract
1-(6-Hydroxy-2-isopropenyl-1-benzofuran-5-yl)-1-ethanone (1), isolated from the roots of Petasites hybridus L., and a series of synthetic benzoxazepine derivatives of compound 1 (2–6) were evaluated for their immunomodulatory effects. The compounds were evaluated for their effects on the respiratory burst of human whole blood and isolated human polymorphonuclear leukocytes (PMNs) using luminol- and lucigenin-based chemiluminescence (CL) assays, and their effect on chemotactic migration of PMNs was assessed using the Boyden chamber technique. Compound 1 exhibited stronger inhibition than acetylsalicylic acid (ASA) on luminol-enhanced CL of PMNs. It also inhibited PMN chemotaxis with an IC50 value comparable to that of ibuprofen. Of the compounds tested, 5 was the most effective in inhibiting luminol-enhanced CL and also strongly inhibited lucigenin-enhanced CL with IC50 values lower than that of ASA. Compound 2 was the most active in inhibiting migration of PMNs and was five times stronger than ibuprofen. The results suggest that compound 1 and its synthesized benzoxazepine derivatives, especially compounds 2 and 5, were able to modulate the innate immune response of phagocytes at different steps, emphasizing their potential as leads for the development of new immunomodulatory agents.
Similar content being viewed by others
References
Beutler B (2004) Innate immunity: an overview. Mol Immunol 40:845–859
Afonso V, Champy R, Mitrovic D, Collin P, Lomri A (2007) Reactive oxygen species and superoxide dismutases: role in joint diseases. Joint Bone Spine 74:324–329
Cottineau B, Toto P, Marot C, Pipaud A, Chenault J (2002) Synthesis and hypoglycemic evaluation of substituted pyrazole-4-carboxylic acids. Bioorg Med Chem Lett 12:2105–2108
Kalkhambkar RG, Aridoss G, Kulkarni GM (2011) Synthesis and biological activities of novel ethers of quinolinone linked with coumarins. Monatshefte fur Chemie 142:305–315
Ghate M, Manohar D, Kulkarni VR, Shobha SY (2003) Kattimani synthesis of vanillin ethers from 4-(bromomethyl) coumarins as anti-inflammatory agents. Eur J Med Chem 38:297–302
Khan IA, Kulkarni MV, Sun CM (2005) One pot synthesis of oxygenated tri-heterocycles as anti-microbial agents. Eur J Med Chem 40:1168–1172
Rostom SAF, Shalaby MA, El-Demellawy MA (2003) Polysubstituted pyrazoles, part 5. Synthesis of new 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazole-3-carboxylic acid hydrazide analogs and some derived ring systems. A novel class of potential antitumor and anti-HCV agents. Eur J Med Chem 38:959–974
Manna K, Agrawal YK (2009) Microwave assisted synthesis of new indophenazine 1,3,5-trisubstituted pyrazoline derivatives of benzofuran and their antimicrobial activity. Bioorg Med Chem Lett 19:2688–2692
Khaleghi F, Din LB, Charati FR, Yaacob WA, Khalilzadeh MA (2011) A new bioactive compound from the roots of Petasites hybridus. Phytochem Lett 4:254–258
Eaton J (1998) Butterbur, herbal help for migraine. Nat Pharm 2:23–24
Mauskop A (2000) Petasites hybridus: ancient medicinal plant is effective prophylactic treatment for migraine. Townsend Lett 202:104–106
Scheidegger C, Dahinden C, Wiesmann U (1998) Effects of extracts and of individual components from Petasites on prostaglandin synthesis in cultured skin fibroblasts and on leucotriene synthesis in isolated human peripheral leucocytes. Pharm Acta Helvetiae 72:376–378
Thomet OAR, Schapowal A, Heinisch IVWM, Wiesmann UN, Simon HU (2002) Anti-inflammatory activity of an extract of Petasites hybridus in allergic rhinitis. Int Immunopharmacol 2:997–1006
Berger D, Burkard W, Schaffner W (1998) Influence of Petasites hybridus on dopamine-D2 and histamine-H1 receptors. Pharm Acta Helv 72:373–375
Danesch UC (2004) Petasites hybridus (Butterbur root) extract in the treatment of asthma—an open trial. Altern Med Rev 9:54–62
Coyne WE, Cusic JW (1967) Antiinflammatory dialkylaminoalkylureas. J Med Chem 10:541–546
Jilek JO, Pomykacek J, Metysova J (1965) Neurotropic and psychotropic substances. III. Derivatives of dibenz[b,f][1,4]oxazepine. Collect Czechoslov Chem Commun 30:463–471
Schmutz J, Hunziker F, Stille G (1967) Chemical structure and pharmacological activity of a new group of tricyclic neuroleptics. XI. Heterocycles with seven atoms. Eur J Med Chem (Chim Ther) 2:424–429
Coyne WE, Cusic JW (1968) Anticonvulsant semicarbazides. J Med Chem 11:1158–1160
Fiorentino A, D’Abrosca B, Pacifico S, Cefarelli G, Uzzo P, Monaco P (2007) Natural dibenzoxazepinones from leaves of Carex distachya: structural elucidation and radical scavenging activity. Bioorg Med Chem Lett 17:636–639
Kamei K, Maeda N, Nomura K, Shibata M, Katsuragi-Ogino R, Koyama M, Nakajima M, Inoue T, Ohno T, Tatsuoka T (2006) Synthesis, SAR studies, and evaluation of 1,4-benz oxazepine derivatives as selective 5-HT1A receptor agonists with neuroprotective effect: discovery of piclozotan. Bioorg Med Chem 14:1978–1992
Lowe EW Jr, Ferrebee A, Rodriguez AL, Conn J, Meiler J (2010) 3D-QSAR CoMFA study of benzoxazepine derivatives as mGluR5 positive allosteric modulators. Bioorg Med Chem Lett 20:5922–5924
Uto Y, Ueno Y, Kiyotsuka Y, Miyazawa Y, Kurata H, Ogata T, Takagi T, Wakimoto S, Ohsumi J (2011) Discovery of novel SCD1 inhibitors: 5-alkyl-4,5-dihydro-3H-spiro[1,5-benzoxazepine-2,41-piperidine] analogs. Eur Med Chem 46:1892–1896
Khaleghi F, Din LB, Jantan I, Yaakob WA, Khalilzadeh A (2011) A facile synthesis of novel 1,4-benzoxazepine-2-one derivatives. Tetrahedron Lett 52:7182–7184
Jantan I, Harun NH, Septama AW, Murad S, Mesaik MA (2011) Inhibition of chemiluminescence and chemotactic activity of phagocytes in vitro by the extracts of selected medicinal plants. J Nat Med 65:400–405
Sacerdote P, Massi P, Panerai AE (2000) In vivo and in vitro treatment with the synthetic cannabinoid CP55,940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors. J Neuroimmunol 109:155–163
Arnhold J (2004) Properties, functions, and secretion of human myeloperoxidase. Biochemistry 69:4–9
Rathakrishnan C, Tiku ML (1993) Lucigenin-dependent chemiluminescence in articular chondrocytes. Free Radic Biol Med 15:143–149
Parij NAM, Nagy AM, Fondu P, Neve J, Parolaro D (1998) Effects on nonsteroidal anti-inflammatory drugs on the luminol- and lucigenin-amplified chemiluminescence of human neutrophils. Eur Pharmacol 352:299–305
Allen A (1986) Phagocytic leucocytic oxygen activities and chemiluminescence: a kinetic approach to analysis. In: Deluca M et al (eds) Methods in enzymology. bioluminescence and chemiluminescence, vol 133B. Academic Press, New York, pp 449–493
Spisani S, Vanzini G, Traniello S (1979) Inhibition of human leucocytes locomotion by anti-inflammatory drugs. Experientia 35:803–804
Acknowledgments
This work was supported by the Ministry of Higher Education, Malaysia, under the Fundamental Research Grant Scheme (FRGS)(grant number 03-FRGS0029-2010).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Khaleghi, F., Jantan, I., Din, L.B. et al. Immunomodulatory effects of 1-(6-hydroxy-2-isopropenyl-1-benzofuran-5-yl)-1-ethanone from Petasites hybridus and its synthesized benzoxazepine derivatives. J Nat Med 68, 351–357 (2014). https://doi.org/10.1007/s11418-013-0805-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11418-013-0805-9